Showing results (2721-2730 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|June 7, 1995
Cost effectiveness of hepatitis A prevention in FranceC A Severo, F Fagnani, A LafumaPharmacoeconomics|July 7, 1995
A Markov process analysis comparing the cost effectiveness of maintenance therapy with citalopram versus standard therapy in major depressionM J Nuijten, M Hardens, E SouêtrePharmacoeconomics|August 6, 1995
A comparative review of pharmacoeconomic guidelinesP Jacobs, J Bachynsky, J F BaladiPharmacoeconomics|May 8, 1994
Translating safety, efficacy and compliance into economic value for controlled release dosage formsM P Cramer, S R SaksPharmacoeconomics|December 9, 1994
Direct and indirect costs of cardiovascular and cerebrovascular complications of type II diabetesK M MacLeod, J E TookePharmacoeconomics|December 9, 1994
Pharmacoeconomics of diabetes surveillance and detection programmesP D HomePharmacoeconomics|October 5, 1995
The economics of orphan drug policy in the US. Can the legislation be improved?J W Peabody, A Ruby, P CannonPharmacoeconomics|October 5, 1995
The economic effects of introducing vigabatrin, a new antiepileptic medicationD Reinharz, W Kennedy, A P Contandriopoulos, et al.Pageof 336